There is lack of knowledge about the safety of treatment with methadone and buprenorphine as part of opioid maintenance treatment (OMT) during pregnancy. The purpose of this study was to examine neonatal outcomes concerning the use of OMT during pregnancy. We used nationwide registry linkages from the Czech Republic (2000-2014) and Norway (2004-2013). We compared prenatally OMT-exposed newborns with (a) newborns of women hospitalized with opioid use disorder during pregnancy in the Czech sample and (b) newborns with neonatal abstinence syndrome (NAS) in Norway. We performed multivariate linear and binary logistic regression exploring the associations between OMT and neonatal outcomes (growth parameters, gestational age, fetal death, small for gestational age, Apgar score, and NAS). Regression coefficients (b) and odds ratios (ORs) were estimated. The cohorts consisted of 333 Czech, and 235 Norwegian OMT-exposed newborns, and 106 and 294 newborns in the comparison groups, respectively. In both countries, the neonatal growth parameters were similar in the OMT and the comparison groups. In Norway, OMT exposure prolonged gestational age (adjusted b = 0.96 weeks, 95% confidence interval [CI] =0.39-1.53) while the odds of preterm birth and Apgar score at 5 minutes were lower than in the comparison group (adjusted OR = 0.35, 0.16-0.75 and aOR = 0.21, 0.06-0.78, respectively). Newborns of women in OMT had similar growth parameters as newborns of women with opioid use disorders who were not in OMT during pregnancy. Overall, our findings do not suggest that OMT results in worse neonatal outcomes.

Department of Addictology 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Chronic Diseases and Ageing Norwegian Institute of Public Health Oslo Norway

Department of Global Public Health and Primary Care University of Bergen Bergen Norway

Department of Mental Disorders Norwegian Institute of Public Health Oslo Norway

Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic

National Monitoring Centre for Drugs and Addiction Office of the Government of the Czech Republic Prague Czech Republic

Norwegian Centre for Addiction Research at the University of Oslo Oslo Norway

Zobrazit více v PubMed

Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363:2320‐2331. PubMed PMC

WHO . Guidelines for identification and management of substance use and substance use disorders in pregnancy. 2014. PubMed

Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am. 1998;25:139‐151. PubMed

Kandall SR, Albin S, Gartner LM, Lee KS, Eidelman A, Lowinson J. The narcotic‐dependent mother: fetal and neonatal consequences. Early Hum Dev. 1977;1:159‐169. PubMed

Kandall SR, Albin S, Lowinson J, Berle B, Eidelman AI, Gartner LM. Differential effects of maternal heroin and methadone use on birthweight. Pediatrics. 1976;58:681‐685. PubMed

Zelson C, Lee SJ, Casalino M. Neonatal narcotic addiction. Comparative effects of maternal intake of heroin and methadone. N Engl J Med. 1973;289:1216‐1220. PubMed

Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta‐analysis. Am J Epidemiol. 2014;180:673‐686. PubMed

Nechanská B, Mravčík V, Skurtveit S, et al. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Addiction. 2018;113:1286‐1294. PubMed PMC

Farid WO, Dunlop SA, Tait RJ, Hulse GK. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol. 2008;6:125‐150. PubMed PMC

Jones HE, Finnegan LP, Kaltenbach K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs. 2012;72:747‐757. PubMed

Norgaard M, Nielsson MS, Heide‐Jorgensen U. Birth and neonatal outcomes following opioid use in pregnancy: a danish population‐based study. Subst Abuse. 2015;9:5‐11. PubMed PMC

Maguire DJ, Taylor S, Armstrong K, et al. Long‐term outcomes of infants with neonatal abstinence syndrome. Neonatal Netw. 2016;35:277‐286. PubMed

Walhovd KB, Watts R, Amlien I, Woodward LJ. Neural tract development of infants born to methadone‐maintained mothers. Pediatr Neurol. 2012;47:1‐6. PubMed

Brogly SB, Hahn KA, Diaz SH,Werler M. Confounding of the comparative safety of prenatal opioid agonist. Therapy. J Addict Res Ther. 2015;6. PubMed PMC

Brogly SB, Hernandez‐Diaz S, Regan E, Fadli E, Hahn KA, Werler MM. Neonatal outcomes in a medicaid population with opioid dependence. Am J Epidemiol. 2018;187:1153‐1161. PubMed PMC

Freund DA, Neuschler E. Overview of medicaid capitation and case‐management initiatives. Health Care Financ Rev. 1986;21‐30. PubMed PMC

Jones HE, Kaltenbach K, Johnson E, Seashore C, Freeman E, Malloy E. Neonatal abstinence syndrome: presentation and treatment considerations. J Addict Med. 2016;10:224‐228. PubMed

Tuten M, Jones HE, Svikis DS. Comparing homeless and domiciled pregnant substance dependent women on psychosocial characteristics and treatment outcomes. Drug Alcohol Depend. 2003;69:95‐99. PubMed

McMahon AW, Dal Pan G. Assessing drug safety in children — the role of real‐world data. N Engl J Med. 2018;378:2155‐2157. PubMed PMC

Norwegian Directorate of Health . National Guidelines for Opioid Maintenance Treatment of Opioid Dependency [Only in Norwegian: Nasjonal retningslinje for legemiddelassistert rehabilitering ved opioidavhengighet]. Oslo: 2010.

Popov P. Methadone substitution treatment in the Czech Republic. [Only in Czech: Metadonová substituční léčba v České republice] Adiktologie. 2002;2:25‐31.

Lund IO, Skurtveit S, Engeland A, Furu K, Ravndal E, Handal M. Prescription drug use among pregnant women in opioid Maintenance Treatment. Addiction (Abingdon, England). 2013;108:367‐376. PubMed

Gabrhelik R, Nechanska B, Mravcik V, Skurtveit S, Lund IO, Handal M. A unique opportunity to study short and long term consequences in children prenatally exposed to illicit drugs and opioid maintenance treatment using Czech and Scandinavian Registers. Cent Eur J Public Health. 2016;24:248‐251. PubMed

WHO Collaborating Centre for Drug Statistics Methodology . ATC Classification Index with DDDs 2013; 2013.

Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85:843‐848. PubMed

Vollset SE. Confidence intervals for a binomial proportion. Stat Med. 1993;12:809‐824. PubMed

Chan E, Leong P, Malouf R, Quigley MA. Long‐term cognitive and school outcomes of late‐preterm and early‐term births: a systematic review. Child Care Health Dev. 2016;42:297‐312. PubMed

Gill JV, Boyle EM. Outcomes of infants born near term. Arch Dis Child. 2017;102:194‐198. PubMed

Holbrook BD. The effects of nicotine on human fetal development. Birth Defects Res Part C, Embryo Today. 2016;108:181‐192. PubMed

Mravčík V, Chomynová P, Grohmannová K, Janíková B, Tion Leštinová Z, Rous Z. Výroční zpráva o stavu ve věcech drog v České republice v roce 2015 (only in Czech; Annual Report on Drug Situation 2015 ‐ the Czech Republic). In: republiky ÚvČ, editor. Praha; 2016.

Gomez‐Pomar E, Finnegan LP. The epidemic of neonatal abstinence syndrome, historical references of its’ origins, assessment, and management. Frontiers in Pediatrics. 2018;6:33. PubMed PMC

Jones HE, O'Grady KE, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict. 2008;17:372‐386. PubMed

Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;CD002209. PubMed

Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction. 2008;103:1429‐1440. PubMed